Orca1

FDA inspection

Jubilant Cadista Pharmaceuticals, Inc.: FDA inspection ending Aug 10, 2007

FDA inspection 483131 · Voluntary Action Indicated (VAI) · Salisbury, MD

Key facts

Inspection ID 483131
Firm Jubilant Cadista Pharmaceuticals, Inc.
FEI number 1000513046
Address 207 Kiley Dr
City Salisbury
State MD
ZIP 21801-2249
Fiscal year 2007
Inspection end date Aug 10, 2007
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections